Skip to main content
Clinical Trials/CTRI/2025/07/091266
CTRI/2025/07/091266CompletedPhase 2/3

Efficacy of Error Augmentation in motor function and balance and its impact on Activities of Daily Living (ADL) in patients with Stroke

MrsYamuna3 sites in 1 country50 target enrollmentStarted: August 1, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Completed
Sponsor
Enrollment
50
Locations
3
Primary Endpoint
Motor function and balance

Study Overview

Brief Summary

Error augmentation techniques are designed to improves functional performance of hand and balance in post stroke patients and this study will check whether these techniques help patients with stroke to get better. This project is about helping people who have had a stroke improve their ability to do everyday activities and feel more confident in managing life on their own. After a stroke, many people find it hard to do simple tasks using hand. Generally, therapy helps by practicing these tasks. All patients in this study will receive conventional occupational performance training. One group will receive only the conventional training, while another group will receive an additional therapy error augmentation along with the conventional training. At the end, both the groups will be compared to see whether error augmentation technique provided additional benefit

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
45.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • First onset of stroke Medically stable patients Clients those who are willing to participate in the study Clients within an age group of 45 to 60 Both genders Clients with subacute Stroke Clients with a score of greater than or equal to 18 in MoCA Clients in stage 4 and 5 in the Brunnstrom recovery stage Clients with a score of 13 to 24 (moderate postural impairment) in the Postural assessment scale for Stroke) Cortical and subcortical stroke meeting the other criteria will be included in the study.

Exclusion Criteria

  • Participants with multiple strokes, bilateral paresis, severe spasticity or contracture, sensory deficits, cerebellar strokes resulting in ataxia, syndromes of strokes, significant shoulder pain, and botulinum toxin injection to the hemiparetic limb.
  • Patients with unilateral neglect and other cognitive perceptual issues like aphasia, apraxia, and visual perceptual deficit Patients with visual and hearing impairment Patient with other neurological deficits like Parkinson’s, dementia, and psychiatric conditions.

Outcomes

Primary Outcomes

Motor function and balance

Time Frame: Motor function and balance at pretest and posttest after 4 weeks

Secondary Outcomes

  • Activities of Daily Living(Activities of Daily Living at pretest & posttest after 4 weeks)

Investigators

Sponsor
MrsYamuna
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Hariprasath M

KMCH College of Occupational Therapy

Study Sites (3)

Loading locations...

Similar Trials